Assessment of the effect of lidocaine on seizure duration and hemodynamic changes in electroconvulsive therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201105103912N2

Enrollment

Registered

2011-06-16

Start date

2011-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ECT. Depressive episode

Interventions

Intervention 1: Intervention group: Lidocaine, 1.5 mg/kg, IV, just before induction of anesthesia. Intervention 2: Control group: Normal saline, IV, with the same volume as the intervention group, jus

Placebo

Intervention group: Lidocaine, 1.5 mg/kg, IV, just before induction of anesthesia

Control group: Normal saline, IV, with the same volume as the intervention group, just before induction of anesthesia

Eligibility

Sex/Gender

All

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 20-40 years, psychiatric disorders with ASAI-II, candidate for ECT Exclusion criteria: heart failure, cardiac arrhythmia, drug hypersensitivity, drug abuse

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duration of seizure. Timepoint: after intervention. Method of measurement: clinical observation.;Blood Pressure. Timepoint: Before and immediately 3 and 5 minutes after ECT. Method of measurement: Pulse Oximetry.;Pulse Rate. Timepoint: Before and immediately and 3 and 5 minutes after ECT. Method of measurement: Pulse Oximetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKobra Noorian

Shahrekord University of Medical Sciences

noorian@skums.ac.irM_ABEDINZADE@yahoo.com+98 38 1333 5648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026